vTv Therapeutics, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 0.33%168.130.7%$1128.30m
PFEPfizer Inc. -0.50%49.610.9%$923.63m
ABBVAbbVie, Inc. -0.43%141.941.9%$816.24m
LLYEli Lilly & Co. 2.76%318.861.1%$806.77m
MRKMerck & Co., Inc. 0.98%91.480.7%$800.70m
BMYBristol-Myers Squibb Co. 1.05%74.911.0%$652.74m
SIGASIGA Technologies, Inc. 2.24%24.860.0%$474.56m
AZNAstraZeneca Plc 0.05%66.771.0%$369.83m
GBTGlobal Blood Therapeutics, Inc. 0.12%67.085.6%$333.13m
GSKGSK Plc -1.31%34.800.3%$280.53m
ALNYAlnylam Pharmaceuticals, Inc. -0.93%226.038.2%$273.95m
VERUVeru, Inc. 8.58%24.160.0%$243.44m
HZNPHorizon Therapeutics Plc -2.36%62.575.4%$215.36m
KRTXKaruna Therapeutics, Inc. 1.22%266.900.0%$207.52m
CCXIChemoCentryx, Inc. 0.14%50.932.9%$202.60m

Company Profile

vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and the Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.